Xiamen Hengkun New - Public Comps and Valuation Multiples

Xiamen Hengkun New Overview

About Xiamen Hengkun New

Xiamen Hengkun New Material Technology Co Ltd is principally engaged in the research and development, production and sales of semiconductor materials, and its products are mainly used in the process of integrated circuit chip manufacturing. Additionally the company is into new material technology promotion services, integrated circuit manufacturing, engineering and technology research and experimental development, manufacturing of special materials for electronics and sales of chemical products, electronic special materials, machinery and equipment, and electronic products. Also, the company is into non-residential real estate leasing.

Founded

2004

HQ

Employees

n/a

Website

hengkun.com

Sectors

Advanced Materials

Financials

Last FY Revenue $77.7M

Last FY EBITDA $24.6M

EV

$3.1B

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Xiamen Hengkun New Financials

See Xiamen Hengkun New valuation multiples based on analyst estimates

Xiamen Hengkun New P&L

In the most recent fiscal year, Xiamen Hengkun New reported revenue of $77.7M and EBITDA of $24.6M.

Xiamen Hengkun New expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Xiamen Hengkun New valuation multiples based on analyst estimates

	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	XXX	$77.7M	XXX	XXX	XXX
Gross Profit	XXX	$41.8M	XXX	XXX	XXX
Gross Margin	XXX	54%	XXX	XXX	XXX
EBITDA	XXX	$24.6M	XXX	XXX	XXX
EBITDA Margin	XXX	32%	XXX	XXX	XXX
EBIT	XXX	$15.3M	XXX	XXX	XXX
EBIT Margin	XXX	20%	XXX	XXX	XXX
Net Profit	XXX	$13.7M	XXX	XXX	XXX
Net Margin	XXX	18%	XXX	XXX	XXX
Net Debt	XXX	$45.4M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Xiamen Hengkun New including revenue, profitability, and margin analysis across different time periods. In the most recent fiscal year, Xiamen Hengkun New achieved $77.7M in revenue and $24.6M in EBITDA.
Financial Metric	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	Analyst estimates available to subscribers	$77.7M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	Analyst estimates available to subscribers	$41.8M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	Analyst estimates available to subscribers	53.8% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	Analyst estimates available to subscribers	$24.6M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	Analyst estimates available to subscribers	31.7% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	Analyst estimates available to subscribers	$15.3M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	Analyst estimates available to subscribers	19.7% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	Analyst estimates available to subscribers	$13.7M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	Analyst estimates available to subscribers	17.7% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	$45.4M	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Xiamen Hengkun New

This financial data table provides comprehensive performance metrics for Xiamen Hengkun New, a company based in China. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Fiscal Year Performance

In the most recent fiscal year, Xiamen Hengkun New reported $77.7M in total revenue.
Fiscal year EBITDA was $24.6M.
The company maintained a gross profit margin of 53.8% in the most recent fiscal year.
EBITDA margin for the fiscal year was 31.7%.
Net profit margin reached 17.7% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Xiamen Hengkun New. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Xiamen Hengkun New Stock Performance

Xiamen Hengkun New has current market cap of CNY 21.2B (or $3.0B), and EV of CNY 21.6B (or $3.1B).

Market Cap Evolution

Xiamen Hengkun New Stock Data

As of December 17, 2025, Xiamen Hengkun New's stock price is CNY 47 (or $7).

See Xiamen Hengkun New trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$3.1B	$3.0B	XXX	XXX	XXX	XXX	n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Xiamen Hengkun New Valuation Multiples

Xiamen Hengkun New's trades at 39.5x EV/Revenue multiple, and 124.7x EV/EBITDA.

See valuation multiples for Xiamen Hengkun New and 15K+ public comps

Xiamen Hengkun New Financial Valuation Multiples

As of December 17, 2025, Xiamen Hengkun New has market cap of $3.0B and EV of $3.1B.

Equity research analysts estimate Xiamen Hengkun New's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Xiamen Hengkun New's P/E ratio is not available.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$3.0B	XXX	$3.0B	XXX	XXX	XXX
EV (current)	$3.1B	XXX	$3.1B	XXX	XXX	XXX
EV/Revenue	n/a	XXX	39.5x	XXX	XXX	XXX
EV/EBITDA	n/a	XXX	124.7x	XXX	XXX	XXX
EV/EBIT	n/a	XXX	200.5x	XXX	XXX	XXX
EV/Gross Profit	n/a	XXX	n/a	XXX	XXX	XXX
P/E	n/a	XXX	218.9x	XXX	XXX	XXX
EV/FCF	n/a	XXX	-99.4x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Xiamen Hengkun New Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Xiamen Hengkun New Margins & Growth Rates

Xiamen Hengkun New's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.

Xiamen Hengkun New's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Xiamen Hengkun New's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Xiamen Hengkun New and other 15K+ public comps

Xiamen Hengkun New Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	n/a	XXX	n/a	XXX	XXX	XXX
EBITDA Margin	n/a	XXX	32%	XXX	XXX	XXX
EBITDA Growth	n/a	XXX	n/a	XXX	XXX	XXX
Rule of 40	n/a	XXX	n/a	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	n/a	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	n/a	XXX	XXX	XXX
Opex per Employee	XXX	XXX	n/a	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	2%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	16%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	34%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial